Free radical-induced lipid peroxidation has been implicated in a number of human diseases including atherosclerosis, cancer, and neurodegenerative diseases. F 2 -Isoprostanes (IsoPs) are isomers of prostaglandin PGF 2α that are generated in vivo from the free radical-initiated peroxidation of arachidonic acid independent of cyclooxygenase enzymes. Since the discovery of the IsoPs in the early 1990s, a large body of evidence has been accumulated to indicate that quantification of these F 2 -IsoPs represents the most reliable biomarker to assess oxidative stress in vivo. A variety of analytical approaches have been developed for the quantification of these novel compounds; these methods include mass spectrometry (MS) detection coupled to gas chromatography (GC) or liquid chromatography (LC) separation, and detection using immunological approaches. This article summarizes our current methodology to quantify F 2 -IsoPs in biological fluids and tissues using GC-MS. This method includes solid-phase extraction (SPE), thin-layer chromatography (TLC) purification, chemical derivatization, and MS detection using negative ion chemical ionization (NICI) coupled with GC. The protocol described herein has been optimized and validated to provide the best sensitivity and selectivity for quantification of F 2 -IsoPs from a variety of biological sources.
Introduction
Free radical-induced autooxidation of polyunsaturated fatty acids (PUFAs) has been linked to numerous human disorders, including atherosclerosis, cancer, neurodegenerative diseases, and aging [1] [2] [3] [4] [5] . Isoprostanes (IsoPs) are a series of prostaglandin (PG)-like compounds that are formed nonenzymatically in vivo via the peroxidation of arachidonic acid by a free radical-initiated mechanism [6] [7] [8] . An important aspect of the formation of IsoPs is that they are generated in situ from arachidonic acid esterified in phospholipids and are subsequently released by phospholipases, such as platelet-activating factor (PAF) acetylhydrolases [9] . On the other hand, the PGs are generated from the oxidation of free arachidonic acid by cyclooxygenases (COXs) [10] . Over the past two decades, quantification of F 2 -IsoPs, isomers of PGF 2α , has emerged as one of the most accurate approaches to assess oxidant injury in vivo [11, 12] . In fact, in the Biomarkers of Oxidative Stress Study (BOSS) sponsored by the National Institute of Health (NIH), F 2 -IsoPs were shown to be the most accurate biomarker to assess in vivo oxidant stress status when compared against other well-known biomarkers [13] . In addition to F 2 -IsoPs, D 2 /E 2 -IsoPs which contain E/D prostane rings analogous to COX-derived PGD 2 and PGE 2 , and isomers of thromboxane, termed isothromboxanes (IsoTxs), are also generated in significant amounts in vivo [14, 15] . Some IsoPs exert potent biological activity by acting as ligands for either plasma membrane bound PG receptors or for nuclear receptors and thus are likely also mediators of oxidant injury [16] [17] [18] . F 2 -IsoPs are stable and robust molecules that are detectable in all human tissues and biological fluids analyzed, including plasma, urine, bronchoalveolar lavage (BAL) fluid, cerebrospinal fluid (CSF), and bile. The quantification of F 2 -IsoPs in urine and plasma is most convenient and least invasive. Several methods have been developed to analyze F 2 -IsoPs; these include chromatographic separation involving solid-phase extraction (SPE) or affinity chromatography with or without thin-layer chromatography (TLC) followed by final determination by gas chromatography-mass spectrometry (GC-MS), liquid chromatography (LC)-MS, or enzyme immunoassay [19] [20] [21] [22] [23] [24] . GC-negative-ion chemical ionization mass spectrometric (GC/NICI-MS) employing stable isotope dilution is the preferred method for the quantification of F 2 -IsoPs and several alternative GC-MS assays have been developed by different investigators including FitzGerald and colleagues [25] . For quantification purposes, we measure 15-F 2t -IsoP (also known as 8-Iso PGF 2α ), and other F 2 -IsoPs that coelute with this compound. The advantages of GC-MS include the high resolution of GC separation on fused silica capillary columns and the specificity and sensitivity of MS, which yield quantitative results in the low picogram range [26, 27] .
A substantial body of evidence indicates that measurement of F 2 -IsoPs in body fluids provides a reliable approach to assess lipid peroxidation in vivo. Based on available data, quantification of these compounds in either plasma or urine is representative of their endogenous production and thus gives a highly precise and accurate index of in vivo oxidant stress [24, 28, 29] . Normal levels of F 2 -IsoPs in healthy humans have been defined [28] [29] [30] . Defining these levels is particularly important in that it allows for an assessment of the effects of diseases on endogenous oxidant tone and allows for the determination of the extent to which various therapeutic interventions affect levels of oxidant stress. Elevations of IsoPs in human body fluids and tissues have been found in a diverse array of human disorders, including atherosclerosis, diabetes, obesity, cigarette smoking, neurodegenerative diseases, and many others [31] . Further, treatments for some of these conditions, including antioxidant supplementation, antidiabetic treatments, cessation of smoking, and even weight loss, have been shown to decrease production of F 2 -IsoPs [32] .
Principles
As has been noted, F 2 -IsoPs are formed nonenzymatically as a result of the free radical-mediated peroxidation of arachidonic acid. The mechanism outlined in Fig. 1 is based on the generation of bicyclic endoperoxide intermediates [33] . Arachidonic acid initially undergoes hydrogen atom abstraction by a free radical at the three bisallylic positions of C7, C10, or C13 to yield a delocalized pentadienyl carboncentered radical. Subsequently, there is an insertion of molecular oxygen to yield peroxyl radicals. These peroxyl radicals undergo further 5-exo cyclization, followed by the addition of another molecule of oxygen to yield the bicyclic endoperoxide (PGG 2 -like) [34] . These intermediates are then reduced to form F 2 -IsoPs. Based on this mechanism, four F 2 -IsoP regioisomers are generated. These are named the 5-, 8-, 12-, and 15-series F 2 -IsoPs, based on the location of the side chain hydroxyl group in the final product [35, 36] . Each series contains 16 possible diastereomers and a total of 64 stereoisomers of F 2 -IsoPs can be generated.
The F 2 -IsoPs are initially formed esterified to phospholipids after the reduction of the bicyclic endoperoxides and the GC-MS can only analyze the derivatives of free F 2 -IsoPs. A derivatization protocol has been developed to make the samples suitable for GC-MS analysis (Fig. 2) . Both esterified and free F 2 -IsoPs can be measured. To analyze the esterified F 2 -IsoPs in tissue samples, the F 2 -IsoPs are first released under basic conditions. After addition of deuterated internal standard, solid-phase extraction is carried out using both C18 and silica Sep-Pak to remove the contaminants. Pentafluorobenzyl (PFB) moiety is then introduced to the molecule to enhance the sensitivity of detection using electron capture chemical ionization techniques [37] . The last step is to cap the hydroxyl groups by trimethylsilyl (TMS) derivatization. Analysis of the derivatives of F 2 -IsoPs and the internal standard is carried out using selective-ion monitoring (SIM) techniques; the ions monitored are m/z 569 for F 2 -IsoPs and m/z 573 for the internal standard respectively. The detailed procedures for the purification and derivatization steps will be described in the Protocol section. 
Protocol
General precautions. Arachidonic acid in biological samples is susceptible to free radical oxidation and thus prevention of the ex vivo oxidation is crucial in the processing and storage of the samples especially plasma and tissue samples that contain abundant arachidonic acid. For the best results, samples should be flash-frozen in liquid nitrogen immediately on collection and not thawed until analysis. BHT and PPh 3 are added to the Folch solution to prevent ex vivo oxidation during the extraction of lipids.
Extraction and hydrolysis of F 2 -IsoP-containing phospholipids in tissues and biological fluids Levels of F 2 -IsoPs in a variety of biological sources can be measured as an accurate index of in vivo oxidant stress status. Although free or esterified F 2 -IsoPs (bound) can be quantified in plasma, we found no advantage in measuring total (free + bound) rather than free F 2 -IsoPs. Thus the present method measures only free F 2 -IsoPs. For urine sample, 24-h urine collection represents a reliable probe for the oxidant stress and only free F 2 -IsoPs is measured. For the tissue samples, the majority of the F 2 -IsoPs are esterified on phospholipids and basic hydrolysis is necessary to release these compounds after extraction of the total lipids from the tissue homogenates. (ii) Homogenized tissue with a blade homogenizer for 30 s or until fully homogenized.
(iii) Flush tube with nitrogen or argon and allow the sealed solution to stand at room temperature for 1 h, shaking occasionally.
(iv) Add 4 ml of aqueous NaCl (0.9%) and vortex vigorously for 1 min.
(v) Centrifuge at 800 g for 10 min at room temperature to separate the aqueous and organic phases. After centrifugation, the upper aqueous layer is discarded and the lower organic layer is carefully separated from the intermediate semisolid protein layer.
(vi) Transfer the organic phase containing the extracted lipids to a 50-ml centrifuge tube and evaporated to dryness under a stream of N 2 .
(vii) Add 2 ml of methanol containing BHT (0.005%) and an equal volume of aqueous KOH (15%). The mixture is then vortexed and flushed with nitrogen before the tube is capped.
(viii) Incubate the mixture at 37°C for 30 min to effectively hydrolyze and release free F 2 -IsoPs.
(ix) Acidify the mixture to pH 3 with 1 N HCl and diluted to a final volume of at least 40 ml with pH 3 water. (Note: Dilution of the methanol in the solution with water to 5% or less is necessary to ensure proper column extraction of F 2 -IsoPs in the subsequent purification procedure.) (B) Biological fluids: 2-3 ml of plasma is added in 7 ml of pH 3 water or 0.25 ml of urine is added in 10 ml of pH 3 water and acidified to pH 3 with 1 N HCl.
Purification, derivatization, and quantification of free 
Calculations and expected results
A representative chromatogram obtained from the analysis of F 2 -IsoPs in mouse liver is shown in Fig. 3 . For quantification purposes, we compare the height of the peak containing the derivatized 15-F 2t -IsoP (m/z 569, peak labeled with ⁎ in Fig. 3 ) with the height of the deuterated internal standard peak (m/z 573). Levels of F 2 -IsoPs in plasma are reported in picograms or nanograms per milliliter, whereas levels in tissues are reported in nanograms per gram of tissue. Levels of F 2 -IsoPs in urine are normalized to creatinine clearance and reported as nanograms per milligrams of creatinine. It should be noted that the peak denoted with "+" in Fig. 3 may also contain the COX product PGF 2α when free F 2 -IsoPs are analyzed in biological fluids, such as plasma, CSF, or urine. However, caution should be exercised regarding the enzymatic origin of this peak; our studies show that the majority of this peak in human urine is actually derived from the free radical pathway [38] . Furthermore, this peak is also present when the esterified F 2 -IsoPs are measured and it can only be derived from the free radical pathway in this case.
Caveats GC-MS methods offer excellent sensitivity and selectivity for F 2 -IsoPs. However, the labor-intensive purification and derivatization steps that are necessary for the GC-MS analysis make it difficult to improve the throughput of the assay. Secondly, experienced and trained personnel are required to set up and operate the rather expensive instrument. In addition to GC-MS methods, a number of LC-MS methods for F 2 -IsoPs analysis have been developed [39] [40] [41] . As noted, F 2 -IsoPs consist of a mixture of four series of regioisomers and each has 16 diastereomers. These different stereoisomers may be formed and metabolized differently; thus the levels of these individual stereoisomers can be altered under various pathophysiological conditions [38, 40] . GC-MS methods quantify all possible F 2 -IsoPs stereoisomers while LC-MS methods permit separation and identification of selected regioisomers and diastereomers of F 2 -IsoPs. The other advantage of LC-MS methods is that the sample preparation for analysis is simpler than that for GC-MS because no derivatization of the molecule is required. In addition to analyzing the free F 2 -IsoPs, we recently also developed a LC-MS method to analyze the intact esterified F 2 -IsoPs on different phospholipid head groups [42] . However, a concern with these LC-MS assays relates to the limits of detection in biological fluids that are often higher than those employing GC-MS [29] . Enzyme immunoassays have also been developed to quantify IsoPs using antibodies which generated against some selected isomers of F 2 -IsoPs, such as 8-iso-15(R)-PGF 2α [43] . Although mass spectrometric methods of F 2 -IsoP quantification are considered the best methods for analysis, immunoassays have expanded research in this area due to their low cost and relative ease of use [28, 29] . However, multistep sample purification is still necessary, and questions remain as to the specificity of the antibody. Studies comparing GC-MS and enzyme immunoassay assays of the same samples have demonstrated that the values from the assays are correlated but not identical [44, 45] .
The measurement of free F 2 -IsoPs in urine can be confounded by the potential contribution of local F 2 -IsoP production in the kidney, although the extent to which this occurs is unclear. In light of this issue, we have identified the primary urinary metabolite of 15-F 2t -IsoP to be 2,3-dinor-5,6-dihydro-15-F 2t -IsoP, and we have developed a highly sensitive and accurate mass spectrometric assay to quantify this molecule [46] . Thus, the quantification of 2, 3-dinor-5,6-dihydro-15-F 2t -IsoP might represent a truly noninvasive, time-integrated measurement of systemic oxidation status that can be applied to living subjects.
